[PDF][PDF] Yoga Waranugraha1, Ardian Rizal1, Mokhamad Fahmi Rizki Syaban2, Icha Farihah Deniyati Faratisha2
NE Erwan, KC Yunita - 2021 - tehj.springeropen.com
Background: To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
[HTML][HTML] Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review …
Background To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …
Real‐World Comparative Effectiveness and Safety of Non‐Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in a Developing Country
P Mitsuntisuk, S Nathisuwan… - Clinical …, 2021 - Wiley Online Library
We aimed to compare effectiveness and safety of the non‐vitamin K antagonist oral
anticoagulants (NOACs) vs. warfarin for stroke prevention in nonvalvular atrial fibrillation …
anticoagulants (NOACs) vs. warfarin for stroke prevention in nonvalvular atrial fibrillation …
Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation: Meta-Analysis of Randomized Trials and Real-World Studies
Z Xue, H Zhang - Stroke, 2019 - Am Heart Assoc
Background and Purpose—Several randomized trials and real-world studies have reported
the efficacy and safety of non–vitamin K antagonist oral anticoagulants (NOACs) in Asian …
the efficacy and safety of non–vitamin K antagonist oral anticoagulants (NOACs) in Asian …
Factors Influencing the Selection of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation
S Park, NK Je - Journal of Cardiovascular Pharmacology …, 2021 - journals.sagepub.com
Background: Major atrial fibrillation (AF) guidelines recommend non-vitamin K antagonist
oral anticoagulants (NOACs) over warfarin, except in rare clinical circumstances based on 4 …
oral anticoagulants (NOACs) over warfarin, except in rare clinical circumstances based on 4 …
[HTML][HTML] Reappraisal of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: a systematic review and meta-analysis
Background: Recent observational studies have compared effectiveness and safety profiles
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …
Long-term effectiveness and safety of non-vitamin K antagonist anticoagulant in real world practice
SY Roh, DY Kim, EL Yoon, H Lee, KN Lee - Europace, 2023 - academic.oup.com
Abstract Funding Acknowledgements Type of funding sources: None. Backgrounds Novel
oral anticoagulants (NOACs) are effective to prevent stroke in patients with atrial fibrillation …
oral anticoagulants (NOACs) are effective to prevent stroke in patients with atrial fibrillation …
Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …
Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular …
CI Coleman, JB Briere, L Fauchier, P Levy… - Journal of market …, 2019 - mdpi.com
Introduction: Numerous real-world studies have compared non-vitamin K antagonist oral
anticoagulants (NOACs) with vitamin K antagonists (VKAs) in patients with non-valvular …
anticoagulants (NOACs) with vitamin K antagonists (VKAs) in patients with non-valvular …
Tolerability and acceptability of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: systematic review and meta-analysis
D Caldeira, N Goncalves, JJ Ferreira, FJ Pinto… - American Journal of …, 2015 - Springer
Background The non-vitamin K antagonist oral anticoagulants (NOACs) overcame some
limitations of vitamin K antagonists (VKAs), and are at least as effective in stroke prevention …
limitations of vitamin K antagonists (VKAs), and are at least as effective in stroke prevention …